机构

• 上海药物研究所 [11]
• 合肥物质科学研究院 [8]
• 自动化研究所 [5]
• 大连化学物理研究所 [3]
• 宁波材料技术与工程研... [2]
• 近代物理研究所 [2]
• 更多

采集方式

• OAI收割 [35]
• iSwitch采集 [1]

内容类型

• 期刊论文 [36]

发表日期

• 2023 [4]
• 2022 [10]
• 2021 [6]
• 2020 [3]
• 2019 [1]
• 2018 [1]
• 更多

学科主题

• Engineerin... [1]
• Materials ... [1]

筛选

浏览/检索结果: 共36条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 A validated LC-MS/MS method for the quantification of bevacizumab in rat, cynomolgus monkey, and human serum 期刊论文  OAI收割 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 卷号: 235, 页码: 11 作者:  Zhou, Ainan;  Yu, Jinghua;  Wu, Yali;  Xue, Hao;  Zhong, Dafang   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/10/17 Monoclonal antibody  Bevacizumab  LC-MS  MS  Surrogate peptide  Pharmacokinetics  Serum   Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文  OAI收割 BMC CANCER, 2023, 卷号: 23 作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping   |  收藏  |  浏览/下载：9/0  |  提交时间：2023/11/10 Hepatocellular carcinoma  Atezolizumab  Bevacizumab  Overall survival  Progression-free survival   Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery 期刊论文  OAI收割 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 卷号: 42, 期号: 1, 页码: 20 作者:  Long, Li;  Xiong, Wei;  Lin, Fenwang;  Hou, Jiazhen;  Chen, Guihua   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 Shikonin  Colorectal cancer liver metastasis  Glycolysis  Pyruvate kinase M2 (PKM2)  Epithelial-mesenchymal transition (EMT)  Immune microenvironment   A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity 期刊论文  OAI收割 MOLECULAR THERAPY, 2023, 卷号: 31, 期号: 1, 页码: 66-77 作者:  Shi, Wenqiang;  Lv, Liangyin;  Liu, Nan;  Wang, Hui;  Wang, Yang   |  收藏  |  浏览/下载：22/0  |  提交时间：2023/04/10 Suppression of Pathological Ocular Neovascularization by a Small Molecular Multi-Targeting Kinase Inhibitor, DCZ19903 期刊论文  OAI收割 TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2022, 卷号: 11, 期号: 12, 页码: 15 作者:  Ding, Jingjuan;  Li, Bo;  Zhang, Huiying;  Xu, Zhijian;  Zhang, Qiuyang   |  收藏  |  浏览/下载：5/0  |  提交时间：2023/10/17 ocular neovascularization  DCZ19903  multitarget kinase inhibitor  network pharmacology  MAPK signaling pathway   The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文  OAI收割 TRANSLATIONAL CANCER RESEARCH, 2022 作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi   |  收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23 Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)  apatinib  case report   Intravitreal injection of EV11, a novel aryl ketone amide, inhibits choroidal neovascularization via AKT/ERK1/2 pathway 期刊论文  OAI收割 MICROVASCULAR RESEARCH, 2022, 卷号: 143, 页码: 7 作者:  Kong, Hongyu;  Zhang, Rong;  Jing, Qinghe;  Liang, Yu;  Zhuo, Qiao   |  收藏  |  浏览/下载：26/0  |  提交时间：2022/11/11 Choroidal neovascularization  Intravitreal injection  AKT  ERK1  2 pathway   Modeling the efficacy of different anti-angiogenic drugs on treatment of solid tumors using 3D computational modeling and machine learning 期刊论文  OAI收割 COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 卷号: 146, 页码: 16 作者:  Mousavi, Milad;  Manshadi, Mahsa Dehghan;  Soltani, Madjid;  Kashkooli, Farshad M.;  Rahmim, Arman   |  收藏  |  浏览/下载：22/0  |  提交时间：2022/09/21 Solid tumor  Tumor growth  Anti-angiogenic drugs  Bevacizumab  Ranibizumab  Brolucizumab  Artificial intelligence  Cancer   Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文  OAI收割 ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11 作者:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia   |  收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23 Breast cancer  nanoparticle-albumin-bound paclitaxel (Nab-P)  taxanes  meta-analysis   Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 11 作者:     |  收藏  |  浏览/下载：37/0  |  提交时间：2022/08/16 nanoparticles  molecular targeted therapy  non-small cell lung cancer  dual-responsive  controlled release